Chart not looking good at the moment
NASDAQ:LMNL Liminal BioSciences Inc
Looks to continue its slide, possibly towards $3.21 or lower. Hard to find where support might wind up here? Nothing good coming out of that quarterly report for investors to bite into. Revenue dropped 41% YOY, the drawdown on their entire line of credit 29.1mil, growing debt, and the issuance of more convertible debt...not helping here. For the moment this looks to be headed much lower unless and until something positive breaks that investors can grab onto.